116 related articles for article (PubMed ID: 38829967)
21. Radiofrequency ablation versus surgical resection of hepatocellular carcinoma: contemporary treatment trends and outcomes from the United States National Cancer Database.
Uhlig J; Sellers CM; Stein SM; Kim HS
Eur Radiol; 2019 May; 29(5):2679-2689. PubMed ID: 30560364
[TBL] [Abstract][Full Text] [Related]
22. Trends and Disparities in Stage-Specific Incidence of Hepatocellular Carcinoma among US Adults, 2004-2019.
Shi H; Huang J; Zhao S; Jin Y; Cai R; Ran J
Liver Cancer; 2023 Aug; 12(3):277-280. PubMed ID: 37767065
[TBL] [Abstract][Full Text] [Related]
23. Impact of the COVID-19 pandemic on the number and short-term outcomes in hepatectomy for hepatocellular carcinoma: Results from the Japanese National Clinical Database, 2018-2021.
Takemura Y; Endo H; Hibi T; Nakano Y; Seishima R; Takeuchi M; Yamamoto H; Maeda H; Hanazaki K; Taketomi A; Kakeji Y; Seto Y; Ueno H; Mori M; Kitagawa Y
Hepatol Res; 2024 Feb; ():. PubMed ID: 38308614
[TBL] [Abstract][Full Text] [Related]
24. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
[TBL] [Abstract][Full Text] [Related]
25. Disparities in Hepatocellular Carcinoma Incidence, Stage, and Survival: A Large Population-Based Study.
Flores YN; Datta GD; Yang L; Corona E; Devineni D; Glenn BA; Bastani R; May FP
Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1193-1199. PubMed ID: 33737301
[TBL] [Abstract][Full Text] [Related]
26. Declining disease burden of HCC in the United States, 1992-2017: A population-based analysis.
Han J; Wang B; Liu W; Wang S; Chen R; Chen M; Fu Z
Hepatology; 2022 Sep; 76(3):576-588. PubMed ID: 35073427
[TBL] [Abstract][Full Text] [Related]
27. The Mortality and Overall Survival Trends of Primary Liver Cancer in the United States.
Lee YT; Wang JJ; Luu M; Noureddin M; Kosari K; Agopian VG; Rich NE; Lu SC; Tseng HR; Nissen NN; Singal AG; Yang JD
J Natl Cancer Inst; 2021 Nov; 113(11):1531-1541. PubMed ID: 34010422
[TBL] [Abstract][Full Text] [Related]
28. Impact of the COVID-19 pandemic on liver disease-related mortality rates in the United States.
Gao X; Lv F; He X; Zhao Y; Liu Y; Zu J; Henry L; Wang J; Yeo YH; Ji F; Nguyen MH
J Hepatol; 2023 Jan; 78(1):16-27. PubMed ID: 35988691
[TBL] [Abstract][Full Text] [Related]
29. Emerging trends in hepatocellular carcinoma incidence and mortality.
Njei B; Rotman Y; Ditah I; Lim JK
Hepatology; 2015 Jan; 61(1):191-9. PubMed ID: 25142309
[TBL] [Abstract][Full Text] [Related]
30. Racial and Ethnic Inequities in Cancer Care Continuity During the COVID-19 Pandemic Among Those With SARS-CoV-2.
Islam JY; Hathaway CA; Hume E; Turner K; Hallanger-Johnson J; Tworoger SS; Camacho-Rivera M
JAMA Netw Open; 2024 May; 7(5):e2412050. PubMed ID: 38767916
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Hepatocellular Carcinoma in Hispanic and Non-Hispanic Patients.
Asemota J; Oladunjoye O; Babalola A; Nwosu U; Liu PS; Oladunjoye AO; Castro-Webb N; Miksad RA
Cureus; 2021 May; 13(5):e14884. PubMed ID: 34104609
[TBL] [Abstract][Full Text] [Related]
32. Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma in the United States: An Update.
Kilani Y; Kamal SAF; Vikash F; Vikash S; Aldiabat M; Alsakarneh S; Aljabiri Y; Sohail H; Kumar V; Numan L; Al Khalloufi K
Dig Dis Sci; 2023 Oct; 68(10):4050-4059. PubMed ID: 37584869
[TBL] [Abstract][Full Text] [Related]
33. Telephone-Only Visits Preserved Hepatocellular Cancer Screening Rates in Patients with Cirrhosis Early in the COVID-19 Pandemic.
Rudnick SR; Ugwuegbu J; Soufleris SJ; Bundy R; Dharod A; Russo MW
Dig Dis Sci; 2023 May; 68(5):1791-1796. PubMed ID: 36562886
[TBL] [Abstract][Full Text] [Related]
34. Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area.
Amaddeo G; Brustia R; Allaire M; Lequoy M; Hollande C; Regnault H; Blaise L; Ganne-Carrié N; Séror O; Larrey E; Lim C; Scatton O; El Mouhadi S; Ozenne V; Paye F; Balladur P; Dohan A; Massault PP; Pol S; Dioguardi Burgio M; Vilgrain V; Sepulveda A; Cauchy F; Luciani A; Sommacale D; Leroy V; Roudot-Thoraval F; Bouattour M; Nault JC;
JHEP Rep; 2021 Feb; 3(1):100199. PubMed ID: 33163949
[TBL] [Abstract][Full Text] [Related]
35. Racial and ethnic disparities in untreated patients with hepatitis C virus-related hepatocellular carcinoma but not in those with sustained virologic response.
Park JE; Nguyen VH; Tsai PC; Toyoda H; Leong J; Guy JE; Yeh ML; Huang CF; Yasuda S; Abe H; Hsu YC; Tseng CH; Liu J; Chen YL; Lin PY; Jun DW; Yoshimaru Y; Ogawa E; Ishigami M; Enomoto M; Tamori A; Uojima H; Wang XZ; Xu Q; Takahashi H; Eguchi Y; Inoue K; Huang DQ; Zhao WJ; Chuang WL; Dai CY; Huang JF; Barnett S; Maeda M; Cheung R; Landis C; Tanaka Y; Roberts LR; Schwartz ME; Kumada T; Yu ML; Nguyen MH
Aliment Pharmacol Ther; 2024 Mar; 59(6):742-751. PubMed ID: 38173278
[TBL] [Abstract][Full Text] [Related]
36. Annual report to the nation on the status of cancer, part I: National cancer statistics.
Henley SJ; Ward EM; Scott S; Ma J; Anderson RN; Firth AU; Thomas CC; Islami F; Weir HK; Lewis DR; Sherman RL; Wu M; Benard VB; Richardson LC; Jemal A; Cronin K; Kohler BA
Cancer; 2020 May; 126(10):2225-2249. PubMed ID: 32162336
[TBL] [Abstract][Full Text] [Related]
37. Does race affect management and survival in hepatocellular carcinoma in the United States?
Hoehn RS; Hanseman DJ; Wima K; Ertel AE; Paquette IM; Abbott DE; Shah SA
Surgery; 2015 Nov; 158(5):1244-51. PubMed ID: 25958069
[TBL] [Abstract][Full Text] [Related]
38. Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics.
Cronin KA; Lake AJ; Scott S; Sherman RL; Noone AM; Howlader N; Henley SJ; Anderson RN; Firth AU; Ma J; Kohler BA; Jemal A
Cancer; 2018 Jul; 124(13):2785-2800. PubMed ID: 29786848
[TBL] [Abstract][Full Text] [Related]
39. Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative Therapies.
Ha J; Yan M; Aguilar M; Tana M; Liu B; Frenette CT; Bhuket T; Wong RJ
J Clin Gastroenterol; 2016; 50(5):423-30. PubMed ID: 26583267
[TBL] [Abstract][Full Text] [Related]
40. Impact and the delivery of loco-regional treatment for hepatocellular carcinoma during the COVID-19 pandemic.
How GY; Pua U
J Interv Med; 2022 Nov; 5(4):180-183. PubMed ID: 36532308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
